After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

Masimo (NASDAQ:MASI – Get Free Report)‘s stock had its “hold” rating reaffirmed by equities research analysts at Needham & Company LLC in a research report issued on Wednesday,Benzinga reports.

Quest Diagnostics DGX is set to release its fourth-quarter 2024 results on Jan. 30 before the market opens. Find the latest ...

Trade secrets remain crucial to companies around the world, preserving their most sensitive and valuable information.

Surmodics, Inc. SRDX demonstrated strong performance in the last reported quarter. Its loss per share was 51.9% narrower than ...